Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
RA Phase III study
.
Show all posts
Showing posts with label
RA Phase III study
.
Show all posts
Friday, March 13, 2015
Can-Fite BioPharma completes RA Phase III study of lead drug candidate CF101
›
Can-Fite BioPharma Ltd. a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and...
›
Home
View web version
